Board of management dr christian mueller thomas simmerer dr ludwin monz

Management Board of Carl Zeiss Meditec AG


Dr ludwin monz

Dr. rer. nat. Ludwin Monz (President and CEO)

Dr. Ludwin Monz, born in 1963, has been President and CEO of Carl Zeiss Meditec AG since March 2010. He has been a Member of the Management Board of Carl Zeiss Meditec AG since 2007. Effective 1 January 2014, he was additionally appointed as a Member of the Executive Board of Carl Zeiss AG.

In this role he is responsible for Corporate Quality Management and Corporate Research and Technology. He also oversees the Japanese, Spanish, French and Turkish sales regions. In addition to his offices as Chairman and Member of the Supervisory Boards of ZEISS companies, he is a member of the Strategy Board of the Henley Business School and a member of the University Council of the Friedrich Schiller University in Jena.

Dr. Monz constantly works on improving the company's competitiveness by adopting a clear innovation orientation in order to facilitate market growth in a difficult market environment. Besides developing suitable innovation and market strategies, especially in the field of software, Dr. Monz also pays particular attention to establishing lean and efficient corporate processes. Under his leadership, a number of products were launched which now serve as benchmarks for the industry.

After obtaining his PhD in physics, Dr. Monz spent a year as an Invited Visiting Scientist at the National Institute of Standards and Technology in Gaithersburg, USA and subsequently worked as a member of the scientific staff at the Gesellschaft für Schwerionenforschung (Society for Heavy Ion Research – GSI) in Darmstadt, Germany, before joining ZEISS as a scientist in 1994. He obtained an MBA from Henley Management College in the UK in 2004. He quickly advanced within the ZEISS organization, starting as Head of Geodetic Systems Product Development, before being made General Manager of this division which he led in a joint venture with a Swedish-American company. He then joined the Medical Technology business group of ZEISS in 2000, where he was initially responsible for the development of surgical microscopes for microsurgery.

Dr. Monz's enthusiasm for science and technology, combined with his interest in medical applications, pays dividends in his work. He has a passion for outdoor pursuits and is a photography enthusiast.

Show more
Dr christian müller

Dr. Christian Müller

Dr. Christian Müller, born in 1967, has been a Member of the Management Board at Carl Zeiss Meditec AG since December 2009, where he is responsible for Finance and Controlling, Investor Relations, and Legal and Taxes.

Furthermore, he is responsible for Service and Quality Management and Regulatory Affairs.

After studying business administration in Frankfurt, and later earning his doctorate, he joined the C&L Deutsche Revision auditing company in 1992 where he successfully oversaw the audits of the annual financial statements of numerous companies. He joined VIAG AG in 1997 where he was in charge of numerous auditing and risk management projects, and successfully influenced the continued development of the company’s control system. He was also involved with various M&A projects during this time. In 1999, he transferred to the chemical wing of the company – Degussa AG – where, in his role as head of finance, he was partly responsible for structuring its expansion.

Müller joined the Carl Zeiss Group in 2002 as Vice President of Corporate Auditing and Risk Management. He quickly succeeded in implementing a very high quality, systematic risk management system that is still used throughout the Group. In this position, Müller successfully managed a series of projects focused on improving the effectiveness and efficiency of processes and systems. Thereafter, he was increasingly involved with M&A projects. In 2006, he transferred to Medical Systems where he was in charge of the newly created Surgical Ophthalmology strategic business unit with sites in Germany, France and Scotland. Since then, he has successfully, actively and emphatically driven the expansion of the strategic business unit and realized the integration of IOLTech SA and Acri.Tec AG.

Show more